Wakunaga Pharmaceutical Of Japan To Enter Indian Market
This article was originally published in PharmAsia News
Executive Summary
Osaka-based Wakunaga Pharmaceutical announced plans to enter the Indian market within the year. The company plans to market over-the-counter drug Kyoleopin and supplements through local Indian wholesalers. Wakunaga's move is to seize upon India's economic development and demand for health products; the company expects to reach ¥100 million in sales during the first year. Wakunaga also plans to enter the Brazilian market, and over the long term, Wakunaga hopes to expand shares in the European market. (Click here for more - Japanese language